Study to develop drugs for chronic mosquito-borne viral diseases

Griffith Enterprise
Published
A new Griffith University study aims to develop drugs to treat alphavirus infection such as Ross River, Chikungunya, O’nyong’nyong and Mayaro viruses which cause debilitating and chronic arthritis. Led by Professor Suresh Mahalingam, head of the Research Group for Emerging Viruses, Inflammation and Therapeutics at Menzies Health Institute Queensland, the $905,080 National Health and Medical […]

Here’s why we don’t have a vaccine for Zika (and other mosquito-borne viruses)

Institute for Glycomics and the Eskitis Institute for Drug Discovery will explore the effects Zika virus has on neurological cells.
Griffith Sciences
Published
By Suresh Mahalingam, Principal Research Leader, Institute for Glycomics As Zika fear rises, especially in the wake of the World Health Organization last night declaring a state of public health emergency, people are inevitably asking why we don’t have a vaccine to protect against the mosquito-borne virus. Zika is generally a mild illness, causing fever, […]